Nuance to Present at Barclays Global Technology, Media and Telecommunications Conference
BURLINGTON, Mass., Dec. 03, 2018 (GLOBE NEWSWIRE) — Nuance Communications, Inc. (NASDAQ: NUAN) today announced it will present at the […]
ManTech Appoints John McNiff as Senior Vice President, Business Development of Mission, Cyber & Intelligence Solutions Group
HERNDON, Va., Dec. 03, 2018 (GLOBE NEWSWIRE) — ManTech (Nasdaq: MANT) today announced that it has named John McNiff as […]
Akoustis Introduces Industry’s First 5.6 GHz WiFi BAW Filter and Ships Samples
– New 5.6 GHz Product is World’s Highest Frequency and Widest Bandwidth WiFi BAW Filter –– Company Now Offers Industry’s […]
Sigma Labs and Fraunhofer IAPT Initiate Research and Development Collaboration
SANTA FE, N.M., Dec. 03, 2018 (GLOBE NEWSWIRE) — Sigma Labs, Inc. (NASDAQ: SGLB) (“Sigma Labs” or the “Company”), a […]
Verizon and Samsung to release 5G smartphone in the U.S. in first half of 2019
NEW YORK, Dec. 03, 2018 (GLOBE NEWSWIRE) — Verizon and Samsung announced their plan to bring one of the first […]
NMI Holdings, Inc. Exercises Option for 2019 Cession Rate Under its Quota Share Reinsurance Treaty
EMERYVILLE, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) — NMI Holdings, Inc. (Nasdaq: NMIH) today announced that National Mortgage Insurance Corporation […]
NV5 Appoints Ivor Jarman Executive Vice President of International Operations
HOLLYWOOD, Fla., Dec. 03, 2018 (GLOBE NEWSWIRE) — NV5 Global, Inc. (Nasdaq: NVEE) (“NV5” or the “Company”), a professional engineering […]
GBT Announces U.S. FDA Agrees with its Proposal Relating to Accelerated Approval Pathway for Voxelotor for the Treatment of Sickle Cell Disease and GBT Plans to Submit New Drug Application (NDA)
Pre-NDA Meeting to be Requested for First Quarter of 2019 Company to Host Conference Call and Webcast Today, Monday, December […]
Gemphire Therapeutics Announces Review of Strategic Alternatives and Provides Corporate Update
LIVONIA, Mich., Dec. 03, 2018 (GLOBE NEWSWIRE) — Gemphire Therapeutics Inc. (NASDAQ: GEMP), a clinical-stage biopharmaceutical company focused on developing […]
Atossa Genetics Announces FDA Approval of Endoxifen for “Expanded Access” as Preoperative Systemic Endocrine Therapy for a U.S. Breast Cancer Patient
SEATTLE, Dec. 03, 2018 (GLOBE NEWSWIRE) — Atossa Genetics Inc. (NASDAQ: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and […]
